We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBC12.L Regulatory News (BC12)

  • There is currently no data for BC12

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close announcement - Interim Report 2016

8 Nov 2016 16:00

RNS Number : 6606O
Better Capital PCC Limited
08 November 2016
 

 

 

BETTER CAPITAL PCC LIMITED

(the "Company")

 

8 November 2016

 

Pre close announcement - Interim Report 2016

 

The Board of Better Capital PCC Limited (the "Company") has received an update from the General Partner of the Better Capital Funds ahead of the release of the Interim Report to 30 September 2016.

 

2009 Cell

 

Gardner continues to perform to expectation. The sale process has commenced and is receiving strong global interest. It is anticipated that negotiations will be concluded with a selected bidder pre-Christmas. 

 

The progress of m-Hance has been slower than planned primarily due to lower monthly sales than budgeted. However, there have been new sales wins and the pipeline is stronger going into Q4 FY16, both in the Microsoft GP and the HighCloud (NetSuite) services.

 

Omnico closed its financial year ended 30 September 2016 with positive EBITDA, a considerable improvement on the loss reported for the prior year. This performance demonstrates a turnaround for the business which has successfully moved away from the legacy custom software development and hardware manufacture to focus on core product development and delivery for Food, Beverage and Retail customers. Opportunities in Hospitality, Entertainment and Retail are looking increasingly positive, particularly in theme parks in the US, Middle East and Asia due to market expansion.

 

SPOT, which is a minority interest in Fund I, is discussed further below.

 

The Board of the Company has been advised by Fund I GP that the 2009 Cell is anticipated to report a modest uplift to NAV as at 30 September 2016 which is largely driven by the performance in Gardner.

 

2012 Cell

 

Everest is expected to close FY16 with positive EBITDA better than prior year albeit, significantly below expectations and potential, and with a much improved order pipeline going into FY17. This follows on from a series of cost reduction and revenue enhancing initiatives launched during the year. Net cash is improved.

 

Recent financial performance in Jaeger has been disappointing. Having enjoyed a strong start to its FY17 financial year through its Spring/ Summer 2016 collection with LFLs, full price sell through and EBITDA ahead of budget, the end of season sale proved very competitive with deeper markdowns and a longer sales period. The start of Autumn/ Winter 2016 sales have been slow with the warm weather affecting sales of outerwear. The consequent increase in competitive promotional activity means that trading continues to be challenging. The business received £3.0 million of new funding from Fund II in September 2016.

 

SPOT is trading profitably with good cash generation, ahead of prior year but below budgeted levels in a fiercely competitive environment. Daily sales were impacted over the summer period following Brexit with margins under pressure mainly due to FX price increases. Cash flow has improved.

 

iNTERTAIN has traded well ahead of prior year although marginally behind expectations. The business performed strongly throughout the Euro 2016 tournament but the prolonged period of hotter than usual weather in July to September was unhelpful to a business with limited outdoor areas. The business has added one new venue since the Annual Report.

 

CAV continues its trend of steady improvement on an operational and financial basis. Considerable progress in areas such as machine maintenance and health and safety have helped improve both product quality and the working environment. Customer arrears are significantly and consistently reducing. The warranty claim process is continuing. Significant restructuring and customer renegotiations continue.

 

Since the Annual Results, Fund II acquired a further 23.7 million Better Capital 2012 Shares ("2012 Shares") with an average gross price of 31.96 pence per share. At 30 September 2016, Fund II held 57.1 million shares (16.47 per cent. of the 2012 Cell share capital). The 2012 Shares are valued based on their quoted closing price at that date of 33.00 pence. Subject to shareholder consents, it is the Company's current intention to acquire up to 50 per cent. of Fund II's holding of the 2012 Shares by way of an off-market transaction and to cancel these on acquisition. Further communication on the matter will be made in due course. 

 

The Fund II GP has advised the Board that the recent underperformance in Everest, Jaeger and SPOT against their respective current year budgets is expected to impact the 2012 Cell NAV as at 30 September 2016 with a current expectation of a decline in the region of 14 per cent. 

 

Further details will be provided in the Interim Results expected to be released on 30 November 2016.

 

 

Enquiries:

 

Better Capital PCC Limited +44 (0) 1481 716 000

Laurence McNairn (Administrator and Company Secretary)

 

Better Capital LLP +44 (0) 20 7440 0840

Bonnie Kraus (Investor Relations)

 

Powerscourt +44 (0) 20 7250 1446

Justin Griffiths

 

Numis Securities +44 (0) 20 7260 1426

Nathan Brown

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSELALTIIR
Date   Source Headline
9th Jun 20207:00 amRNSReconstruction of the Everest Business
8th Jun 20207:00 amRNSReplacement RNS
5th Jun 20206:08 pmRNSReconstruction of the Everest Business
27th May 20207:00 amRNSDirector/PDMR Shareholding
26th May 20207:00 amRNSHolding(s) in Company
14th May 20201:32 pmRNSPartial Sale of The SPOT Group and their assets
12th May 20204:16 pmRNSResults of Extraordinary General Meetings
1st May 20205:18 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSNotice of Extraordinary General Meetings
1st Apr 20204:00 pmRNSChange of Name of Administrator/Company Secretary
26th Mar 20207:00 amRNSUpdate following COVID-19 outbreak
23rd Dec 20193:25 pmRNSInterim Results Update
12th Nov 20195:50 pmRNSHolding(s) in Company
12th Sep 20192:23 pmRNSResult of AGM
23rd Aug 20197:00 amRNSNotice of AGM
22nd Aug 20199:28 amRNSDirector Declaration
1st Aug 20197:00 amRNSTotal Voting Rights
2nd Jul 20197:01 amRNS2012 Cell Distribution of Capital
2nd Jul 20197:00 amRNS2012 Shares Buyback
1st Jul 20197:00 amRNSFinal Results Update
21st May 20193:08 pmRNSDirector/PDMR Shareholding
29th Apr 20193:00 pmRNSChange of Registered Office
1st Apr 20197:00 amRNSSpicers-OfficeTeam - Partial Disposal
25th Jan 20195:18 pmRNSHolding(s) in Company
23rd Jan 20194:40 pmRNSHolding(s) in Company
22nd Jan 20192:41 pmRNSDirector/PDMR Shareholding
10th Dec 20184:30 pmRNSDirector/PDMR Shareholding
5th Dec 201812:03 pmRNSDirector Declaration
3rd Dec 20187:00 amRNSInterim Results Update
29th Oct 20185:00 pmRNSPreliminary NAV views as at 30 September 2018
13th Sep 20183:30 pmRNSResults of AGMs
5th Sep 201811:59 amRNSDirector/PDMR Shareholding
3rd Sep 20189:39 amRNSHolding(s) in Company
31st Aug 20184:09 pmRNSHolding(s) in Company
31st Aug 201812:45 pmRNSDirector/PDMR Shareholding
22nd Aug 20184:30 pmRNSEverest Valuation at 31st March 2018/SPOT Progress
10th Aug 20182:37 pmRNSHolding(s) in Company
6th Aug 20187:00 amRNSNotice of Annual General Meetings
3rd Aug 201810:11 amRNSHolding(s) in Company
26th Jul 201811:00 amRNSDistribution of Capital
24th Jul 20185:18 pmRNSDirector/PDMR Shareholding
23rd Jul 20184:41 pmRNSSecond Price Monitoring Extn
23rd Jul 20184:35 pmRNSPrice Monitoring Extension
23rd Jul 20187:00 amRNSFurther Update Re: Sale of Northern Aerospace Ltd
13th Jul 20187:00 amRNSFinal Results Update
9th Jul 20187:00 amRNSFurther update re sale of Northern Aerospace Ltd
2nd Jul 20187:00 amRNSTotal Voting Rights
26th Jun 20185:00 pmRNSStatement re Annual Report & Financial Statements
25th Jun 20187:00 amRNSFurther Update Re: Sale of Northern Aerospace
19th Jun 201810:02 amRNSFurther Re: Sale of Northern Aerospace Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.